Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 24Recruiting 12Completed 6Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 21Breast 5Gynecologic 4Head & Neck 3Thoracic 2Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Laryngeal Neoplasms 1

Interventions

Cisplatin 28toripalimab 14Radiotherapy 12Gemcitabine 12Capecitabine 11Radiotherapy, Intensity-Modulated 10pembrolizumab 9Surgical Procedures, Operative 9Docetaxel 9tislelizumab 8Carboplatin 7Drug Therapy 6Blood Specimen Collection 6anlotinib 5Taxes 5Paclitaxel 5Nivolumab 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cetuximab 5Thyroxine 4Cyclophosphamide 4130-nm albumin-bound paclitaxel 4trametinib 3sintilimab 3camrelizumab 3Specimen Handling 3Radiation 3Observation 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × camrelizumab × Head & Neck × Clear all
NCT07555860 2026-04-29

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Not yet recruiting
28 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 3 Not yet recruiting
246 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07400094 2026-02-10

NeoCamre-HN

National Medical Research Radiological Centre of the Ministry of Health of Russia

Phase 2 Not yet recruiting
50 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡